Vandana Khungar, MD, MSc
Associate Professor of Medicine; Vice-Chief for Diversity, Equity and Inclusion, Section of Digestive Diseases; Associate Medical Director of Liver Transplant, Transplantation Center; Medical Director of Outpatient and Outreach Transplant Hepatology, Transplantation Center
Research & Publications
Biography
News
Coauthors
Selected Publications
- Prevalence and factors associated with statin use among patients with non-alcoholic fatty liver disease in TARGET-NASHThomson MJ, Serper M, Khungar V, Weiss LM, Trinh H, Firpi-Morell R, Roden M, Loomba R, Barritt AS, Gazis D, Mospan AR, Fried MW, Reddy KR, Lok AS. Prevalence and factors associated with statin use among patients with non-alcoholic fatty liver disease in TARGET-NASH Clinical Gastroenterology And Hepatology 2021, 20: 458-460.e4. PMID: 33775894, PMCID: PMC8464616, DOI: 10.1016/j.cgh.2021.03.031.
- Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver DiseasesSarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP, Afshar Y, Terrault NA. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases Hepatology 2021, 73: 318-365. PMID: 32946672, DOI: 10.1002/hep.31559.
- The Mucosally-Adherent Rectal Microbiota Contains Features Unique to Alcohol-Related CirrhosisShen TD, Daniel SG, Patel S, Kaplan E, Phung L, Lemelle-Thomas K, Chau L, Herman L, Trisolini C, Stonelake A, Toal E, Khungar V, Bittinger K, Reddy KR, Wu GD. The Mucosally-Adherent Rectal Microbiota Contains Features Unique to Alcohol-Related Cirrhosis Gut Microbes 2021, 13: 1987781. PMID: 34747331, PMCID: PMC8583005, DOI: 10.1080/19490976.2021.1987781.
- Predictors, Presentation, and Treatment Outcomes of Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Large Single Center ExperienceEkpanyapong S, Philips N, Loza BL, Abt P, Furth EE, Tondon R, Khungar V, Olthoff K, Shaked A, Hoteit MA, Reddy KR. Predictors, Presentation, and Treatment Outcomes of Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Large Single Center Experience Journal Of Clinical And Experimental Hepatology 2019, 10: 304-315. PMID: 32655233, PMCID: PMC7335705, DOI: 10.1016/j.jceh.2019.11.003.
- Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver TransplantationThiruvengadam NR, Forde KA, Chandrasekhara V, Ahmad NA, Ginsberg GG, Khungar V, Kochman ML. Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation Clinical Gastroenterology And Hepatology 2019, 18: 1224-1232.e1. PMID: 31622734, DOI: 10.1016/j.cgh.2019.10.014.
- Reducing Hospital Admissions for Paracentesis: A Quality Improvement InterventionSiddique SM, Porges S, Lane-Fall M, Mehta SJ, Schweickert W, Kinniry J, Taylor A, Lewis JD, Iqbal S, Goldberg D, Shea JA, Stetson R, Coniglio M, Hoteit M, Fishman N, Khungar V. Reducing Hospital Admissions for Paracentesis: A Quality Improvement Intervention Clinical Gastroenterology And Hepatology 2019, 17: 2630-2633.e2. PMID: 31518719, PMCID: PMC6874893, DOI: 10.1016/j.cgh.2019.09.001.
- Transient elastography reliably estimates liver fibrosis in autoimmune hepatitisMahmud N, Doshi SD, Forde KA, Khungar V. Transient elastography reliably estimates liver fibrosis in autoimmune hepatitis Clinical And Experimental Hepatology 2019, 5: 244-249. PMID: 31598562, PMCID: PMC6781822, DOI: 10.5114/ceh.2019.87639.
- An Automated Text Message Navigation Program Improves the Show Rate for Outpatient ColonoscopyMahmud N, Doshi SD, Coniglio MS, Clermont M, Bernard D, Reitz C, Khungar V, Asch DA, Mehta SJ. An Automated Text Message Navigation Program Improves the Show Rate for Outpatient Colonoscopy Health Education & Behavior 2019, 46: 942-946. PMID: 31431077, PMCID: PMC6889043, DOI: 10.1177/1090198119869964.
- Improving cirrhosis care: The potential for telemedicine and mobile health technologiesStotts MJ, Grischkan JA, Khungar V. Improving cirrhosis care: The potential for telemedicine and mobile health technologies World Journal Of Gastroenterology 2019, 25: 3849-3856. PMID: 31413523, PMCID: PMC6689809, DOI: 10.3748/wjg.v25.i29.3849.
- An Advanced Practice Practitioner–Based Program to Reduce 30‐ and 90‐Day Readmissions After Liver TransplantationMahmud N, Halpern S, Farrell R, Ventura K, Thomasson A, Lewis H, Olthoff KM, Levine MH, Nazarian S, Khungar V. An Advanced Practice Practitioner–Based Program to Reduce 30‐ and 90‐Day Readmissions After Liver Transplantation Liver Transplantation 2019, 25: 901-910. PMID: 30947393, PMCID: PMC6548546, DOI: 10.1002/lt.25466.
- Exploring opportunities to prevent cirrhosis admissions in the emergency department: A multicenter multidisciplinary surveySiddique SM, Lane‐Fall M, McConnell MJ, Jakhete N, Crismale J, Porges S, Khungar V, Mehta SJ, Goldberg D, Li Z, Schiano T, Regan L, Orloski C, Shea JA. Exploring opportunities to prevent cirrhosis admissions in the emergency department: A multicenter multidisciplinary survey Hepatology Communications 2018, 2: 237-244. PMID: 29507899, PMCID: PMC5831018, DOI: 10.1002/hep4.1141.
- Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET studySaxena V, Khungar V, Verna EC, Levitsky J, Brown RS, Hassan MA, Sulkowski MS, O'Leary JG, Koraishy F, Galati JS, Kuo AA, Vainorius M, Akushevich L, Nelson DR, Fried MW, Terrault N, Reddy KR. Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study Hepatology 2017, 66: 1090-1101. PMID: 28504842, PMCID: PMC5756478, DOI: 10.1002/hep.29258.
- Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinomaYu JC, Neugut AI, Wang S, Jacobson JS, Ferrante L, Khungar V, Lim E, Hershman DL, Brown RS, Siegel AB. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma Cancer 2010, 116: 1801-1809. PMID: 20143441, PMCID: PMC3664455, DOI: 10.1002/cncr.24936.
Clinical Trials
| Conditions | Study Title |
|---|---|
| Diseases of the Digestive System - Liver | A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment (AHFIRM) |
| Diseases of the Endocrine System; Genetics - Adult | A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY) |